Learn about the development process behind a new, state-of-the-art fill/finish isolator that's addressing issues in isolator manufacturing and servicing, as well as meeting the needs of the liquid pharmaceutical market.
When it comes to fill/finish manufacturing of parenteral liquid pharmaceuticals, your choice of barrier technology is crucial. Assess air handling obstacles and learn how a fully integrated, turnkey barrier and fill/finish technology can help pave your way to achieving high levels of product integrity and viability.
How can you address the decontamination challenges associated with isolated fill/finish operations? New innovations, such as low-concentration Vapor Phase Hydrogen Peroxide, are being implemented to ensure superior sporicidal reduction and operational safety.
AST’s ASEPTiCell® and GENiSYS® systems combine industry-proven technologies such as robotics and isolator-barrier systems to provide flexible pharmaceutical aseptic filling and closing of ready-to-use vials, syringes, and cartridges with a single machine.
Are you seeking flexibility for the aseptic filling of liquid pharmaceuticals? Designed with the specific challenges of small-batch production in mind, this aseptic processing system can be built to meet the needs of your facility today and for years to come.
Gain advanced and intuitive solutions for automated aseptic processing of liquid pharmaceutical products with a system designed for small-scale filling applications, including research and development, engineering runs, clinical trials, through to commercial production runs.
Does an isolator need to be ergonomically unfriendly to clean? Explore a new fill-finish isolator that prioritizes sterility while providing a user-friendly solution to specific points of friction routinely encountered by operators.
